Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.
Clinical trial NCT02203643 · COMPLETED
Trial details
- NCT number
- NCT02203643
- Sponsor
- Mario Boccadoro
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-10-01
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.